{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"atlas","updatedThrough":"2026-08-15","guardrail":"The atlas exposes only relationships declared in the current public data. A link or issue grouping does not make unlike measures comparable, establish ownership or control, define an antitrust market, assign liability, or show that a policy event caused an economic outcome.","filters":{"depth":2,"edgeType":"all","edgeTypeMatched":true,"focus":"source:ftc-pbm-interim-2024","focusMatched":true,"kind":"all","kindMatched":true,"layer":"measurement","layerMatched":true,"query":"","view":"network"},"summary":{"nodeCount":5478,"edgeCount":19193,"sourceCount":45,"profileCount":5433,"nodeKindCount":13,"layerCount":4,"eligibleEdgeCount":18549,"matchedNodeCount":4,"plottedEdgeCount":3,"plottedNodeCount":4,"hiddenNodeCount":0,"directNeighborCount":1},"focusNode":{"id":"source:ftc-pbm-interim-2024","kind":"source","label":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","shortLabel":"Federal Trade Commission","description":"FTC interim staff report and press release on PBM concentration and vertical integration.","href":"/sources/ftc-pbm-interim-2024","metricLabel":"Access date","metricValue":"2026-05-16","detail":"Federal Trade Commission","status":"agency report","year":2026,"color":"#64748b","searchText":"ftc-pbm-interim-2024 pharmacy benefit managers: the powerful middlemen inflating drug costs and squeezing main street pharmacies federal trade commission ftc interim staff report and press release on pbm concentration and vertical integration. federal trade commission, ftc releases interim staff report on prescription drug middlemen, july 9 2024. agency_report","connectionCount":4},"nodes":[{"id":"source:ftc-pbm-interim-2024","kind":"source","label":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","shortLabel":"Federal Trade Commission","description":"FTC interim staff report and press release on PBM concentration and vertical integration.","href":"/sources/ftc-pbm-interim-2024","metricLabel":"Access date","metricValue":"2026-05-16","detail":"Federal Trade Commission","status":"agency report","year":2026,"color":"#64748b","searchText":"ftc-pbm-interim-2024 pharmacy benefit managers: the powerful middlemen inflating drug costs and squeezing main street pharmacies federal trade commission ftc interim staff report and press release on pbm concentration and vertical integration. federal trade commission, ftc releases interim staff report on prescription drug middlemen, july 9 2024. agency_report","connectionCount":4,"distance":0,"labelVisible":true,"radius":20,"x":450,"y":260},{"id":"market:mkt-pbm","kind":"market","label":"U.S. pharmacy benefit management","shortLabel":"PBMs","description":"Pharmacy benefit management services profile based on FTC public findings. The FTC reports top-three and top-six aggregate shares but not enough individual PBM market shares in the public press-release record to compute HHI.","href":"/markets/us-pharmacy-benefit-management","metricLabel":"HHI status","metricValue":"Withheld","detail":"United States / 2023","status":"incomplete","year":2023,"color":"#14b8a6","searchText":"u.s. pharmacy benefit management pbms health care united states pharmacy benefit management services profile based on ftc public findings. the ftc reports top-three and top-six aggregate shares but not enough individual pbm market shares in the public press-release record to compute hhi.","connectionCount":10,"x":450,"y":112,"distance":1,"radius":11,"labelVisible":true},{"id":"industry:524292","kind":"industry","label":"Pharmacy benefit management and other third party administration of insurance and pension funds","shortLabel":"524292 Pharmacy benefi...","description":"2022 Economic Census employer-firm concentration screen for NAICS 524292.","href":"/industries/524292","metricLabel":"Revenue HHI","metricValue":"1,633.5","detail":"2.5K firms / 283.6B revenue","status":"published","year":2022,"color":"#f59e0b","searchText":"524292 pharmacy benefit management and other third party administration of insurance and pension funds 52","connectionCount":5,"x":471.391,"y":22.963,"distance":2,"radius":8,"labelVisible":false},{"id":"source:bls-cpi-public-data-2026","kind":"source","label":"Consumer Price Index, U.S. city average monthly series","shortLabel":"U.S. Bureau of Labor...","description":"Official non-seasonally-adjusted monthly Consumer Price Index series for nine U.S. city average item universes from January 2017 through July 2026, including publisher-declared and unreturned monthly gaps.","href":"/sources/bls-cpi-public-data-2026","metricLabel":"Access date","metricValue":"2026-08-13","detail":"U.S. Bureau of Labor Statistics","status":"public dataset","year":2026,"color":"#64748b","searchText":"bls-cpi-public-data-2026 consumer price index, u.s. city average monthly series u.s. bureau of labor statistics official non-seasonally-adjusted monthly consumer price index series for nine u.s. city average item universes from january 2017 through july 2026, including publisher-declared and unreturned monthly gaps. u.s. bureau of labor statistics, consumer price index public data, u.s. city average monthly series, accessed august 13 2026. public_dataset","connectionCount":10,"x":428.609,"y":497.037,"distance":2,"radius":8,"labelVisible":false}],"rows":[{"id":"consumer-price-context:mkt-pbm:prescription-drugs","layer":"measurement","relationshipType":"consumer_price_context","relationshipLabel":"Consumer price context","fromId":"market:mkt-pbm","fromKind":"market","fromLabel":"U.S. pharmacy benefit management","fromHref":"/markets/us-pharmacy-benefit-management","toId":"source:bls-cpi-public-data-2026","toKind":"source","toLabel":"Consumer Price Index, U.S. city average monthly series","toHref":"/sources/bls-cpi-public-data-2026","evidenceLabel":"U.S. Bureau of Labor Statistics / CUUR0000SEMF01","evidenceDetail":"Prescription drugs is attached to PBMs as a broad BLS consumer-price context series. Retail prescription-drug prices are attached as consumer context for the PBM dossier; they do not measure PBM services, rebates, spreads, pharmacy reimbursement, margins, or competitive effects.","sourceId":"bls-cpi-public-data-2026","sourceUrl":"https://www.bls.gov/cpi/data.htm","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A broad consumer-price series is attached only as descriptive context. It does not establish product equivalence, an antitrust market, concentration, market power, margins, pass-through, welfare, competitive effects, or causation."},{"id":"industry-screen:mkt-pbm:524292","layer":"measurement","relationshipType":"industry_screen","relationshipLabel":"Declared Census screen","fromId":"market:mkt-pbm","fromKind":"market","fromLabel":"U.S. pharmacy benefit management","fromHref":"/markets/us-pharmacy-benefit-management","toId":"industry:524292","toKind":"industry","toLabel":"Pharmacy benefit management and other third party administration of insurance and pension funds","toHref":"/industries/524292","evidenceLabel":"Market definition crosswalk","evidenceDetail":"U.S. pharmacy benefit management uses NAICS 524292 as declared economy-wide context while preserving a separate product and geographic definition.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"high","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A declared NAICS link supplies economy-wide screening context and is not a legal product or geographic market definition."},{"id":"market-source:mkt-pbm:ftc-pbm-interim-2024","layer":"measurement","relationshipType":"market_source","relationshipLabel":"Market evidence custody","fromId":"market:mkt-pbm","fromKind":"market","fromLabel":"U.S. pharmacy benefit management","fromHref":"/markets/us-pharmacy-benefit-management","toId":"source:ftc-pbm-interim-2024","toKind":"source","toLabel":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies","toHref":"/sources/ftc-pbm-interim-2024","evidenceLabel":"Federal Trade Commission","evidenceDetail":"Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies supports the profile's definition, observation.","sourceId":"ftc-pbm-interim-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A source link identifies evidence used by a market profile and does not endorse every claim in the underlying record."}]}